Publiserte artikler 2009

  1. Aas GB, Aagnes B, Strand LA, Grimsrud TK. Suggested excess of occupational cancers in Norwegian offshore workers: preliminary results from the Cancer Registry Offshore Cohort. Scand J Work Environ Health 2009; 35(5):397-399.
  2. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009; 45(15):2640-2648.
  3. Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R. Comparative cancer survival information in Europe. Eur J Cancer 2009; 45(6):901-908.
  4. Bilet EF, Langseth H, Thoresen SO, Bray F. Completeness of invasive cervical cancer at the Cancer Registry of Norway. Acta Oncol 2009; 48(7):1070-1073.
  5. Bjorge T, Cnattingius S, Engeland A, Tretli S, Lie RT, Lukanova A. Fetal Down syndrome and the risk of maternal breast cancer. Epidemiology 2009; 20(4):584-589.
  6. Braaten T, Weiderpass E, Lund E. Socioeconomic differences in cancer survival: the Norwegian Women and Cancer Study. BMC Public Health 2009; 9:178.
  7. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Scand J Gastroenterol 2009; 44(1):46-55.
  8. Brackmann S, Andersen SN, Aamodt G, Roald B, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Two distinct groups of colorectal cancer in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15(1):9-16.
  9. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009; 45(5):747-755.
  10. Bray F. Cancer in Norway 2008: Cancer incidence, mortality, survival and prevalence in Norway. Dillner J, Langseth H, Gislefoss R, Martinsen JI, Storaas A, Lauritzen M et al., editors. Special issue: The Janus Serum Bank - From sample collection to cancer research. 7-93. 2009. Oslo, Cancer Registry of Norway.
    Ref Type: Generic
  11. Brenner H, Francisci S, De Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Allemani C, Ciccolallo L, Coleman M, Sant M. Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer 2009; 45(6):1028-1041.
  12. Bretthauer M. The First Transatlantic Symposium on colorectal cancer screening. Endoscopy 2009; 41(9):816-817.
  13. Bretthauer M. The capsule and colorectal-cancer screening--the crux of the matter. N Engl J Med 2009; 361(3):300-301.
  14. Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, Lagiou P, Trichopoulos D, Ahrens W, Pigeot I, Merletti F, Richiardi L, Talamini R, Barzan L, Macfarlane GJ, Macfarlane TV, Holcatova I, Bencko V, Benhamou S, Bouchardy C, Kjaerheim K, Lowry R, Agudo A, Castellsague X, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy CM, Marron M, Brennan P. Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res 2009; 69(7):2956-2965.
  15. Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009; 4(7):792-801.
  16. Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol 2009; 27(6):967-973.
  17. Dalgard OS, Sorensen T, Sandanger I, Nygard JF, Svensson E, Reas DL. Job demands, job control, and mental health in an 11-year follow-up study: Normal and reversed relationships. Work and Stress 2009; 23(3):284-296.
  18. De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A, Crocetti E, Pury P, Knijn A, Coleman M, Capocaccia R. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009; 45(6):909-930.
  19. Deltour I, Johansen C, Auvinen A, Feychting M, Klaeboe L, Schuz J. Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst 2009; 101(24):1721-1724.
  20. Døssland MEV, Jensen I.A., Hofvind S. Omtak av røntgen thorax-undersøkelser ved Oslo Universitetssykehus, Ullevål. Hold pusten 2009;(7):12-15.
  21. Eliasen M, Kjaer SK, Munk C, Nygard M, Sparen P, Tryggvadottir L, Liaw KL, Gronbaek M. The relationship between age at drinking onset and subsequent binge drinking among women. Eur J Public Health 2009; 19(4):378-382.
  22. Ferrari P, Roddam A, Fahey MT, Jenab M, Bamia C, Ocke M, Amiano P, Hjartaker A, Biessy C, Rinaldi S, Huybrechts I, Tjonneland A, Dethlefsen C, Niravong M, Clavel-Chapelon F, Linseisen J, Boeing H, Oikonomou E, Orfanos P, Palli D, Santucci dM, Bueno-de-Mesquita HB, Peeters PH, Parr CL, Braaten T, Dorronsoro M, Berenguer T, Gullberg B, Johansson I, Welch AA, Riboli E, Bingham S, Slimani N. A bivariate measurement error model for nitrogen and potassium intakes to evaluate the performance of regression calibration in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr 2009; 63 Suppl 4:S179-S187.
  23. Finstad SE, Emaus A, Tretli S, Jasienska G, Ellison PT, Furberg AS, Wist EA, Thune I. Adult height, insulin, and 17beta-estradiol in young women. Cancer Epidemiol Biomarkers Prev 2009; 18(5):1477-1483.
  24. Folkesson J, Engholm G, Ehrnrooth E, Kejs AM, Pahlman L, Harling H, Wibe A, Gaard M, Thornorvaldur J, Tryggvadottir L, Brewster DH, Hakulinen T, Storm HH. Rectal cancer survival in the Nordic countries and Scotland. Int J Cancer 2009; 125(9):2406-12.
  25. Fournier A, Weiderpass E. Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women. Climacteric 2009; 12(5):410-418.
  26. Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, Gatta G, Sant M, Zigon G, Bray F, Janssen-Heijnen M. The cure of cancer: a European perspective. Eur J Cancer 2009; 45(6):1067-1079.
  27. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, Pastore G, Peris-Bonet R, Stiller CA. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009; 45(6):992-1005.
  28. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009; 47(5):596-603.
  29. Glavin K, Smith L, Sorum R. Prevalence of postpartum depression in two municipalities in Norway. Scand J Caring Sci 2009; 23(4):705-710.
  30. Gondos A, Holleczek B, Janssen-Heijnen M, Brewster DH, Bray F, Rosso S, Hakulinen T, Brenner H. Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. Int J Cancer 2009; 125(11):2666-2672.
  31. Gondos A, Bray F, Hakulinen T, Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009; 20(3):564-73.
  32. Gram IT, Braaten T, Lund E, Le Marchand L, Weiderpass E. Cigarette smoking and risk of colorectal cancer among Norwegian women. Cancer Causes Control 2009; 20(6):895-903.
  33. Grindedal EM, Moller P, Eeles R, Stormorken AT, Bowitz-Lothe IM, Landro SM, Clark N, Kvale R, Shanley S, Maehle L. Germ-line mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomarkers Prev 2009; 18(9):2460-2467.
  34. Hagen AI, Tretli S, Maehle L, Apold J, Veda N, Moller P. Survival in Norwegian BRCA1 mutation carriers with breast cancer. Hered Cancer Clin Pract 2009; 7(1):7.
  35. Haugen M, Bray F, Grotmol T, Tretli S, Aalen OO, Moger TA. Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations. Biostatistics 2009; 10(3):501-514.
  36. Hemminki K, Tretli S, Sundquist J, Johannesen TB, Granstrom C. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol 2009; 10(5):481-488.
  37. Hoff G, Ottestad PM, Skaflotten SR, Bretthauer M, Moritz V. Quality assurance as an integrated part of the electronic medical record - a prototype applied for colonoscopy. Scand J Gastroenterol 2009; 44(10):1259-1265.
  38. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009; 338:b1846.
  39. Hofvind S, Vee B, Sorum R, Hauge M, Ertzaas AKO. Quality assurance of mammograms in the Norwegian Breast Cancer Screening Program. European Journal of Radiography 2009; 1(1):22-29.
  40. Hofvind S, Yankaskas BC, Bulliard JL, Klabunde CN, Fracheboud J. Comparing interval breast cancer rates in Norway and North Carolina: results and challenges. J Med Screen 2009; 16(3):131-139.
  41. Hofvind S, Geller BM, Rosenberg RD, Skaane P. Screening-detected Breast Cancers: Discordant Independent Double Reading in a Population-based Screening Program. Radiology 2009; 253(3):652-660.
  42. Jetne V, Kvaloy S, Smeland S, Johannesen TB, Tveit KM. [Use of radiotherapy in South-Eastern Norway Regional Health Authority]. Tidsskr Nor Laegeforen 2009; 129(24):2602-2605.
  43. Jullumstro E, Lydersen S, Moller B, Dahl O, Edna TH. Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. Eur J Cancer 2009; 45(13):2383-2390.
  44. Kalager M, Haldorsen T, Bretthauer M, Hoff G, Thoresen SO, Adami HO. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 2009; 11(4):R44.
  45. Kalager M, Karesen R, Wist E. [Survival after breast cancer--differences between Norwegian counties]. Tidsskr Nor Laegeforen 2009; 129(24):2595-2600.
  46. Kalager M, Bretthauer M. Spontaneous regression of invasive breast cancer: does this study answer the question? Arch Intern Med 2009; 169(10):997.
  47. Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Love A, Mahlamaki E, Thoresen S, Tryggvadottir L, Wadell G, Youngman L, Lehtinen M. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 2009; 169(4):480-488.
  48. Klungsoyr O, Nygard M, Skare G, Eriksen T, Nygard JF. Validity of self-reported Pap smear history in Norwegian women. J Med Screen 2009; 16(2):91-97.
  49. Klungsoyr O, Sexton J, Sandanger I, Nygard JF. Sensitivity analysis for unmeasured confounding in a marginal structural Cox proportional hazards model. Lifetime Data Anal 2009; 15(2):278-294.
  50. Kroger J, Ferrari P, Jenab M, Bamia C, Touvier M, Bueno-de-Mesquita HB, Fahey MT, Benetou V, Schulz M, Wirfalt E, Boeing H, Hoffmann K, Schulze MB, Orfanos P, Oikonomou E, Huybrechts I, Rohrmann S, Pischon T, Manjer J, Agren A, Navarro C, Jakszyn P, Boutron-Ruault MC, Niravong M, Khaw KT, Crowe F, Ocke MC, van der Schouw YT, Mattiello A, Bellegotti M, Engeset D, Hjartaker A, Egeberg R, Overvad K, Riboli E, Bingham S, Slimani N. Specific food group combinations explaining the variation in intakes of nutrients and other important food components in the European Prospective Investigation into Cancer and Nutrition: an application of the reduced rank regression method. Eur J Clin Nutr 2009; 63 Suppl 4:S263-S274.
  51. Kuper H, Yang L, Sandin S, Lof M, Adami HO, Weiderpass E. Prospective study of solar exposure, dietary vitamin D intake, and risk of breast cancer among middle-aged women. Cancer Epidemiol Biomarkers Prev 2009; 18(9):2558-2561.
  52. Kvale R, Moller B, Wahlqvist R, Fossa SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int 2009; 103(12):1647-1654.
  53. Kvarme LG, Haraldstad K, Helseth S, Sorum R, Natvig GK. Associations between general self-efficacy and health-related quality of life among 12-13-year-old school children: a cross-sectional survey. Health Qual Life Outcomes 2009; 7:85.
  54. Lagiou P, Talamini R, Samoli E, Lagiou A, Ahrens W, Pohlabeln H, Benhamou S, Bouchardy C, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Macfarlane GJ, Biggs AM, Barzan L, Canova C, Simonato L, Lowry RJ, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy CM, Marron M, Hashibe M, Brennan P. Diet and upper-aerodigestive tract cancer in Europe: the ARCAGE study. Int J Cancer 2009; 124(11):2671-2676.
  55. Lagiou P, Georgila C, Minaki P, Ahrens W, Pohlabeln H, Benhamou S, Bouchardy C, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Agudo A, Castellsague X, Macfarlane TV, Macfarlane GJ, Talamini R, Barzan L, Canova C, Simonato L, Lowry R, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy C, Nelis M, Metspalu A, Marron M, Hashibe M, Brennan PJ. Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. Eur J Cancer Prev 2009; 18(1):76-84.
  56. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Moller B. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45(7):1218-1231.
  57. Lee YC, Marron M, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H, Lagiou P, Trichopoulos D, Agudo A, Castellsague X, Bencko V, Holcatova I, Kjaerheim K, Merletti F, Richiardi L, Macfarlane GJ, Macfarlane TV, Talamini R, Barzan L, Canova C, Simonato L, Conway DI, McKinney PA, Lowry RJ, Sneddon L, Znaor A, Healy CM, McCartan BE, Brennan P, Hashibe M. Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case-control study. Cancer Epidemiol Biomarkers Prev 2009; 18(12):3353-3361.
  58. Liestol K, Tretli S, Tverdal A, Maehlen J. Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910-49. Int J Epidemiol 2009; 38(2):427-434.
  59. Lof M, Weiderpass E. Impact of diet on breast cancer risk. Curr Opin Obstet Gynecol 2009; 21(1):80-85.
  60. Lof M, Hilakivi-Clarke L, Sandin SS, de Assis S, Yu W, Weiderpass E. Dietary fat intake and gestational weight gain in relation to estradiol and progesterone plasma levels during pregnancy: a longitudinal study in Swedish women. BMC Womens Health 2009; 9:10.
  61. Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer? APMIS 2009; 117(9):644-650.
  62. Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta G, De Angelis R. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009; 45(6):1017-1027.
  63. Moller B, Langmark F. Kreftoverlevere i tall. In: Fossa SD, Loge JH, Dahl AA, editors. Kreftoverlevere - Ny kunnskap og nye muligheter i et langtidsperspektiv. Oslo: Gyldedals Akademisk, 2009: 30-40.
  64. Mutyaba T, Mirembe F, Sandin S, Weiderpass E. Male partner involvement in reducing loss to follow-up after cervical cancer screening in Uganda. Int J Gynaecol Obstet 2009; 107(2):103-106.
  65. Nygard JF, Klungsoyr O, Sandanger I, Svensson E. Selection effects in psychiatric epidemiology: A 14-year prospective study of the Hopkins Symptom Check List-25 as a predictor of mortality in the Norwegian general population. Soc Psychiatry Psychiatr Epidemiol 2009; 44(10):881-886.
  66. Ocke MC, Larranaga N, Grioni S, van den Berg SW, Ferrari P, Salvini S, Benetou V, Linseisen J, Wirfalt E, Rinaldi S, Jenab M, Halkjaer J, Jakobsen MU, Niravong M, Clavel-Chapelon F, Kaaks R, Bergmann M, Moutsiou E, Trichopoulou A, Lauria C, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Hjartaker A, Parr CL, Tormo MJ, Sanchez MJ, Manjer J, Hellstrom V, Mulligan A, Spencer EA, Riboli E, Bingham S, Slimani N. Energy intake and sources of energy intake in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 2009; 63 Suppl 4:S3-15.
  67. Olsen JH, Moller T, Anderson H, Langmark F, Sankila R, Tryggvadottir L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S. Lifelong Cancer Incidence in 47 697 Patients Treated for Childhood Cancer in the Nordic Countries. J Natl Cancer Inst 2009; 101(11):806-813.
  68. Orem J, Maganda A, Mbidde EK, Weiderpass E. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer 2009; 52(4):455-458.
  69. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 2009; 45(5):756-764.
  70. Parr CL, Hjartaker A, Laake P, Lund E, Veierod MB. Recall bias in melanoma risk factors and measurement error effects: a nested case-control study within the Norwegian Women and Cancer Study. Am J Epidemiol 2009; 169(3):257-266.
  71. Pedersen JI, Hjartåker A, Anderssen S.A. Grunnleggende ernæringslære. Oslo: Gyldendal Akademisk, 2009.
  72. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, Weiderpass E, Kjaerheim K. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol 2009; 48(5):646-790.
  73. Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, Blair A, Rothman N, McGlynn KA. Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environ Health Perspect 2009; 117(10):1514-1519.
  74. Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, Colonna M, Grande E, Grosclaude P, Vercelli M. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009; 45(6):1006-1016.
  75. Reas DL, Nygard JF, Sorensen T. Do quitters have anything to lose? Changes in body mass index for daily, never, and former smokers over an 11-year period (1990-2001). Scand J Public Health 2009; 37(7):774-777.
  76. Rogne SG, Konglund A, Meling TR, Scheie D, Johannesen TB, Ronning P, Helseth E. Intracranial tumor surgery in patients >70 years of age: is clinical practice worthwhile or futile? Acta Neurol Scand 2009; 120(5):288-294.
  77. Rohrmann S, Linseisen J, Vrieling A, Boffetta P, Stolzenberg-Solomon RZ, Lowenfels AB, Jensen MK, Overvad K, Olsen A, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Misirli G, Lagiou P, Trichopoulou A, Kaaks R, Bergmann MM, Boeing H, Bingham S, Khaw KT, Allen N, Roddam A, Palli D, Pala V, Panico S, Tumino R, Vineis P, Peeters PH, Hjartaker A, Lund E, Redondo Cornejo ML, Agudo A, Arriola L, Sanchez MJ, Tormo MJ, Barricarte GA, Lindkvist B, Manjer J, Johansson I, Ye W, Slimani N, Duell EJ, Jenab M, Michaud DS, Mouw T, Riboli E, Bueno-de-Mesquita HB. Ethanol intake and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2009; 20(5):785-794.
  78. Rosso S, De Angelis R, Ciccolallo L, Carrani E, Soerjomataram I, Grande E, Zigon G, Brenner H. Multiple tumours in survival estimates. Eur J Cancer 2009; 45(6):1080-1094.
  79. Rossow I, Mehlum L, Gjertsen F, Moller B. Chain of care for patients with intentional self-harm: an effective strategy to reduce suicide rates? Suicide Life Threat Behav 2009; 39(6):614-622.
  80. Samuelsen SO, Bakketeig LS, Tretli S, Johannesen TB, Magnus P. Birth weight and childhood cancer. Epidemiology 2009; 20(4):484-487.
  81. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45(6):931-991.
  82. Saunes M, Lund Nilsen TI, Johannesen TB. Incidence of primary cutaneous T-cell lymphoma in Norway. Br J Dermatol 2009; 160(2):376-379.
  83. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10(11):1033-1034.
  84. Skeie G, Braaten T, Hjartaker A, Brustad M, Lund E. Cod liver oil, other dietary supplements and survival among cancer patients with solid tumours. Int J Cancer 2009; 125(5):1155-1160.
  85. Skeie G, Braaten T, Hjartaker A, Lentjes M, Amiano P, Jakszyn P, Pala V, Palanca A, Niekerk EM, Verhagen H, Avloniti K, Psaltopoulou T, Niravong M, Touvier M, Nimptsch K, Haubrock J, Walker L, Spencer EA, Roswall N, Olsen A, Wallstrom P, Nilsson S, Casagrande C, Deharveng G, Hellstrom V, Boutron-Ruault MC, Tjonneland A, Joensen AM, Clavel-Chapelon F, Trichopoulou A, Martinez C, Rodriguez L, Frasca G, Sacerdote C, Peeters PH, Linseisen J, Schienkiewitz A, Welch AA, Manjer J, Ferrari P, Riboli E, Bingham S, Engeset D, Lund E, Slimani N. Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr 2009; 63 Suppl 4:S226-S238.
  86. Skog A, Martinsen JI, Aalen OO, Tom K.Grimsrud. Sola-prosjektet: Kartlegging av kreftforekomst blant tidligere ansatte ved A/S Norske Shells nedlagte oljeraffineri på Sola, og blant bosatte i området rundt raffineriet. Oslo: Kreftregisteret, 2009.
  87. Slimani N, Deharveng G, Southgate DA, Biessy C, Chajes V, van Bakel MM, Boutron-Ruault MC, McTaggart A, Grioni S, Verkaik-Kloosterman J, Huybrechts I, Amiano P, Jenab M, Vignat J, Bouckaert K, Casagrande C, Ferrari P, Zourna P, Trichopoulou A, Wirfalt E, Johansson G, Rohrmann S, Illner AK, Barricarte A, Rodriguez L, Touvier M, Niravong M, Mulligan A, Crowe F, Ocke MC, van der Schouw YT, Bendinelli B, Lauria C, Brustad M, Hjartaker A, Tjonneland A, Jensen AM, Riboli E, Bingham S. Contribution of highly industrially processed foods to the nutrient intakes and patterns of middle-aged populations in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr 2009; 63 Suppl 4:S206-S225.
  88. Stensheim H. Langtidseffekter av kreftbehandling. Utposten 2009; 38(3):14-18.
  89. Stensheim H. Malignant melanoma and pregnancy. Onkologie 2009; 32(12):715-716.
  90. Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-Specific Survival for Women Diagnosed With Cancer During Pregnancy or Lactation: A Registry-Based Cohort Study. J Clin Oncol 2009; 27(1):45-51.
  91. Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 2009; 6(12):e1000201.
  92. Syse A, Tretli S, Kravdal O. The impact of cancer on spouses' labor earnings: a population-based study. Cancer 2009; 115(18 Suppl):4350-4361.
  93. Syse A, Aas GB. Marriage after cancer in older adulthood. J Cancer Surviv 2009; 3(1):66-71.
  94. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009; 100(3):450-454.
  95. Tretli S. Risikofaktorer og forebygging. In: Kåresen R, Wist E, editors. Kreftsykdommer: en basisbok for helsepersonell. Oslo: Gyldendal akademisk, 2009: 36-42.
  96. Tretli S. Forekomst av kreft. In: Kåresen R, Wist E, editors. Kreftsykdommer: en basisbok for helsepersonell. Oslo: Gyldendal akademisk, 2009: 27-35.
  97. Trope A, Sjoborg K, Eskild A, Cuschieri K, Eriksen T, Thoresen S, Steinbakk M, Laurak V, Jonassen CM, Westerhagen U, Jacobsen MB, Lie AK. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 2009; 47(8):2458-2464.
  98. Vallieres E, Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, Shaikh Z, Goldstraw P. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4(9):1049-1059.
  99. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009; 45(6):1042-1066.
  100. Weedon-Fekjaer H, Sorum R, Brenn MK. Hormone therapy use may explain recent results regarding tumor regression. Arch Intern Med 2009; 169(10):996-997.
  101. Weedon-Fekjaer H. Fordeler og ulemper ved mammografiscreening: Hvorfor utføre mammografiscreening? Hva er kostnadene? Utposten 2009; 38(6):28-33.
  102. Westgaard A, Laronningen S, Mellem C, Eide TJ, Clausen OP, Moller B, Gladhaug IP. Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma. Eur J Cancer 2009; 45(16):2850-2859.
  103. Wiklund F, Tretli S, Choueiri TK, Signoretti S, Fall K, Adami HO. Risk of bilateral renal cell cancer. J Clin Oncol 2009; 27(23):3737-3741.
  104. Yang L, Kuper H, Sandin S, Margolis KL, Chen Z, Adami HO, Weiderpass E. Reproductive history, oral contraceptive use, and the risk of ischemic and hemorrhagic stoke in a cohort study of middle-aged Swedish women. Stroke 2009; 40(4):1050-1058.
  105. Zaikova O, Giercksky KE, Fossa SD, Kvaloy S, Johannesen TB, Skjeldal S. A Population-based Study of Spinal Metastatic Disease in South-East Norway. Clin Oncol (R Coll Radiol ) 2009; 21(10):753-759.